Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice

被引:49
作者
Dong, Pengzhi [1 ,3 ]
Pan, Lanlan [1 ,3 ]
Zhang, Xiting [1 ,3 ]
Zhang, Wenwen [2 ]
Wang, Xue [6 ]
Jiang, Meixiu [5 ]
Chen, Yuanli
Duan, Yajun [2 ,4 ]
Wu, Honghua [1 ,3 ]
Xu, Yantong [1 ,3 ]
Zhang, Peng [1 ,3 ]
Zhu, Yan [1 ,3 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China
[2] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China
[3] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China
[4] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China
[5] Nanchang Univ, Inst Translat Med, Nanchang 330031, Jiangxi, Peoples R China
[6] Harbin Inst Technol, Acad Fundamental & Interdisciplinary Sci, Harbin 150080, Peoples R China
基金
中国国家自然科学基金;
关键词
Hawthorn (Crataegus pinnatifida Bunge); leave flavonoids; Atherosclerosis; Reverse cholesterol transport; Foam cell; LOW-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; DEFICIENT MICE; CELLULAR CHOLESTEROL; MEDICINAL-PLANTS; OXIDATIVE DAMAGE; TANGIER-DISEASE; HUMAN PLASMA; IN-VIVO; ACTIVATION;
D O I
10.1016/j.jep.2017.01.040
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Hawthorn (Crataegus pinnatifida Bunge) leave have been used to treat cardiovascular diseases in China and Europe. Hawthorn leave flavonoids (HLF) are the main part of extraction. Whether hawthorn leave flavonoids could attenuate the development of atherosclerosis and the possible mechanism remain unknown. Materials and methods: High-fat diet (HFD) mixed with HLF at concentrations of 5 mg/kg and 20 mg/kg were administered to apolipoprotein E (apoE) knock out mice. 16 weeks later, mouse serum was collected to determine the lipid profile While the mouse aorta dissected was prepared to measure the lesion area. Hepatic mRNA of genes involved in lipid metabolism were determined. Peritoneal macrophages were collected to study the impact of HLF on cholesterol efflux, formation of foam cell and the expression of ATP binding cassette transporter Al (ABCA1). Besides, in vivo reverse cholesterol transport (RCT) was conducted. Results: HLF attenuated the development of atherosclerosis that the mean atherosclerotic lesion area in en face aortas was reduced by 23.1% (P < 0.05). In mice fed with 20 mg/kg HLF, Total cholesterol (TC) level was decreased by 18.6% and very low density lipoprotein cholesterol plus low density lipoprotein cholesterol (VLDLc+LDLc) level were decreased by 23.1% whereas high density lipoprotein cholesterol (HDLc) and triglyceride (TG) levels were similar compared to that of the control group. Peroxisome proliferator activated receptor alpha (PPARa) mRNA was increased by 31.2% (P < 0.05) and 60.9% (P < 0.05) in mice fed with 5 mg/ kg and 20 mg/kg HLF respectively. Sterol regulatory element binding protein-1c (SREBP-1c) was decreased by 59.3% in the group of 20 mg/kg. Carnitine palmitoyl transferase 1 (CPT-1) mRNA level of 20 mg/kg group was induced 66.7% (P < 0.05). Superoxide dismutase 1 and 2 (SOD1 and SOD2) mRNA were induced 25.4% (P < 0.05) and 71.4% (P < 0.05) while induced by 36.3% (P < 0.05) and 73.2% (P < 0.05) in group of 20 mg/kg. Glutathione peroxidase 3 (Gpx3) mRNA in the group of 20 mg/kg was induced by 96.7% (P < 0.05). Hepatic hydroxymethylglutaryl CoA reductase (HMG-CoAR) expression was as same level as the control group while LDL receptor (LDLR) mRNA and protein were induced by 84.2% (P < 0.05) and 98.8% (P < 0.05) in group of 20 mg/kg. HLF inhibit the formation of foam cell by 27.9% (P < 0.05) in the dosage of 25 mu g/ml, and 33.3% (P < 0.05) in the dosage of 50 mu g/ml. HLF increased the reverse cholesterol transport (RCT) in vivo. Discussion and conclusion: Hawthorn leave flavonoids can slow down the development of atherosclerosis in apoE knockout mice via induced expression of genes involved in antioxidant activities, inhibition of the foam cell formation and promotion of RCT in vivo, which implies the potential use in the prevention of atherosclerosis.
引用
收藏
页码:479 / 488
页数:10
相关论文
共 57 条
[1]
The roles of different pathways in the release of cholesterol from macrophages [J].
Adorni, Maria Pia ;
Zimetti, Francesca ;
Billheimer, Jeffrey T. ;
Wang, Nan ;
Rader, Daniel J. ;
Phillips, Michael C. ;
Rothblat, George H. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2453-2462
[2]
Studies on pharmaceutical ethnobotany in the region of Pallars (Pyrenees, Catalonia, Iberian Peninsula).: Part II.: New or very rare uses of previously known medicinal plants [J].
Agelet, A ;
Vallès, J .
JOURNAL OF ETHNOPHARMACOLOGY, 2003, 84 (2-3) :211-227
[3]
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages [J].
Aiello, RJ ;
Brees, D ;
Bourassa, PA ;
Royer, L ;
Lindsey, S ;
Coskran, T ;
Haghpassand, M ;
Francone, OL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :630-637
[4]
Transcriptional activities of nuclear SREBP-1a,-1c, and-2 to different target promoters of lipogenic and cholesterogenic genes [J].
Amemiya-Kudo, M ;
Shimano, H ;
Hasty, AH ;
Yahagi, N ;
Yoshikawa, T ;
Matsuzaka, T ;
Okazaki, H ;
Tamura, Y ;
Iizuka, Y ;
Ohashi, K ;
Osuga, J ;
Harada, K ;
Gotoda, T ;
Sato, R ;
Kimura, S ;
Ishibashi, S ;
Yamada, N .
JOURNAL OF LIPID RESEARCH, 2002, 43 (08) :1220-1235
[5]
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[6]
British Herbal Pharmacopoeia, 1983, BRIT HERB PHARM
[7]
A novel approach to prevent endothelial hyperpermeability: The Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway [J].
Bubik, Martin F. ;
Willer, Elisabeth A. ;
Bihari, Peter ;
Juergenliemk, Guido ;
Ammer, Hermann ;
Krombach, Fritz ;
Zahler, Stefan ;
Vollmar, Angelika M. ;
Fuerst, Robert .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 52 (01) :196-205
[8]
Hawthorn: Potential roles in cardiovascular disease [J].
Chang, WT ;
Dao, J ;
Shao, ZH .
AMERICAN JOURNAL OF CHINESE MEDICINE, 2005, 33 (01) :1-10
[9]
Chen Jidi, 2002, Zhonghua Yufang Yixue Zazhi, V36, P172
[10]
Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice [J].
Chen, Yuanli ;
Duan, Yajun ;
Yang, Xiaoxiao ;
Sun, Lei ;
Liu, Mengyang ;
Wang, Qixue ;
Ma, Xingzhe ;
Zhang, Wenwen ;
Li, Xiaoju ;
Hu, Wenquan ;
Miao, Robert Q. ;
Xiang, Rong ;
Hajjar, David P. ;
Han, Jihong .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (04) :948-959